GMED vs LIN · P/E 42, rev $1.55B vs P/E 34, rev $18.07B
Globus Medical (GMED) versus Linde plc Ordinary Shares (LIN) — a side-by-side from cached financials, not a winner call.
Globus Medical (GMED) is a medical devices company listed on US.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Latest reported GMED revenue for 2026-06-30 was $1.55B. Net income was $275.9M. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
Latest reported LIN revenue for 2026-06-30 was $18.07B. Net income was $3.79B. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
GMED currently screens at market cap $7.66B and trailing P/E 42.1. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Not investment advice. Open the GMED and LIN stock pages for the full models.
Not investment advice.